Cancer
IDO199-207 (HLA-A*02:01) ALLEIASCL
Product number: EP11307_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide IDO199-207 (HLA-A*02:01) with the amino acid sequence ALLEIASCL is a linear peptidic epitope (epitope ID 1075176) studied as part of Indoleamine 2,3-dioxygenase 1 (UniProt:P14902) from Homo sapiens (human).
IDO199-207 (HLA-A*02:01) has been studied for immune reactivity in publications and has been tested in T cell assays.
TechData
| Sequence: | ALLEIASCL |
| Gene: | IDO |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Indoleamine 2,3-dioxygenase 1 |
| UniProt Id: | P14902 |
| IEDB Id: | 1075176 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Indication: | Cancer, Infectious disease, Autoimmune disease |
| Purity: | 95% HPLC-MS |